Chest Shielding in Premature Infants During Phototherapy

University of Rochester50 enrolled

Overview

This is a feasibility study where Infants will be randomized to either chest shielding with aluminum foil or chest shielding without aluminum foil while undergoing phototherapy for premature infants. The primary outcome is patent ductus arteriosus.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

TRIPLE

Enrollment

Conditions

Patent Ductus Arteriosus in Premature Infants

Interventions

Chest shield with aluminum foil (CALF)DEVICE

SHIELDDEVICE

Eligibility

Sex: ALLMin age: 23 WeeksMax age: 33 Weeks

Medical Language ↔ Plain English

Inclusion Criteria: * less or equal to 29 weeks or 1000g at birth * Admitted to the NICU (Neonatal intensive care unit) within 24 hours after birth * English speaking parents Exclusion Criteria: * Congenital abnormalities * Chromosomal disorders * Cyanotic heart defects * Nitric oxide * Prophylactic phototherapy * Unlikely to survive beyond 72 hours according to the attending neonatologist * Do not require phototherapy

Locations (1)

University of Rochester

Rochester, New York, United States

Outcomes

Primary Outcomes

Incidence of symptomatic Patent ductus arteriosus

Time frame: During first 2 weeks

Secondary Outcomes

Urinary Nitric oxide level

Time frame: During first 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.